Journal of Laryngology and Otology 2008-12-01

Intralesional triamcinolone acetonide injection in hypertrophic skin surrounding the percutaneous titanium implant of a bone-anchored hearing aid.

J B Van Rijswijk, E A M Mylanus

Index: J. Laryngol. Otol. 122(12) , 1368-70, (2008)

Full Text: HTML

Abstract

We present a patient with persistent hypertrophic skin surrounding the percutaneous implant of a bone-anchored hearing aid system, successfully treated with intralesional applied corticosteroids.Case report and review of the world literature concerning bone-anchored hearing aid implantation and intralesional applied corticosteroids for the treatment of hypertrophic scars and keloids.Eight weeks after revision surgery to reduce surplus skin and subcutaneous scar tissue overgrowing the abutment, skin and subcutaneous scar tissue overgrowth reoccurred. As an alternative to yet another surgical procedure, the hypertrophic skin was treated with intralesional injections of triamcinolone acetonide. Three weeks after the treatment, a satisfying result was seen, and no subsequent relapse was observed.To our knowledge, this is the first, photographically well documented case report of a patient with persistent hypertrophic skin surrounding a percutaneous bone-anchored hearing aid implant, successfully treated with intralesional applied corticosteroids.


Related Compounds

  • Triamcinolone acet...

Related Articles:

Novel Nrf2 activators from microbial transformation products inhibit blood-retinal barrier permeability in rabbits.

2015-03-01

[Br. J. Pharmacol. 172(5) , 1237-49, (2015)]

Evaluation of the reporting level to detect triamcinolone acetonide misuse in sports.

2015-01-01

[J. Steroid Biochem. Mol. Biol. 145 , 94-102, (2015)]

A general analytical platform and strategy in search for illegal drugs.

2014-11-01

[J. Pharm. Biomed. Anal. 100 , 215-29, (2014)]

Detection and characterization of triamcinolone acetonide metabolites in human urine by liquid chromatography/tandem mass spectrometry after intramuscular administration.

2014-08-30

[Rapid Commun. Mass Spectrom. 28(16) , 1829-39, (2015)]

Verteporfin therapy and triamcinolone acetonide: convergent modes of action for treatment of neovascular age-related macular degeneration.

2006-01-01

[Eur. J. Ophthalmol. 16(6) , 824-34, (2006)]

More Articles...